Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis
Clinical trial NCT02040298 · COMPLETED
Trial details
- NCT number
- NCT02040298
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.